Clariant International Ltd

Clariant’s 31st Annual General Meeting approves all agenda items

• Management Report, Financial Statements and Consolidated Financial Statements, Non-financial Report, and Compensation Report of Clariant for the 2025 financial year approved
• Stable distribution of CHF 0.42 per share confirmed
• Ben van Beurden, Chairman of the Board of Directors, confirmed in office
• Regula Wallimann and Albert Manifold join the Board of Directors, which reduces its size from eleven to eight members

MUTTENZ, APRIL 1, 2026

Clariant, a sustainability-focused specialty chemical company, today held its 31^st Annual General Meeting (AGM) where shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The meeting in Basel, Switzerland, was attended by 269 shareholders and shareholder representatives accounting for 224’126’357 shares or around 67.52 % of the share capital of Clariant.

The Management Report, the Financial Statements, the Consolidated Financial Statements of Clariant for the 2025 financial year were approved with 99.93 % of the votes. The 2025 Compensation Report was also approved on an advisory basis with 91.13 % of the votes. The Non-financial Report for the 2025 financial year was approved within the framework of an advisory vote with 96.26 % of the votes. The members of the Board of Directors and the Executive Steering Committee were discharged with 99.67 % of the votes.

The Annual General Meeting reelected Ben van Beurden as Chairman of the Board of Directors until the Annual General Meeting 2027 with 98.55 %. The other members of the Board of Directors standing for reelection were also reelected by a large majority until the next Annual General Meeting. Regula Wallimann, Swiss national, and Albert Manifold, Irish national, were voted by a large majority to join the Board of Directors. Ben van Beurden, Albert Manifold, Claudia Suessmuth-Dyckerhoff, and Ahmed Mohammed Al Umar were elected to constitute the Compensation Committee.

Following the proposal by the Board of Directors, the shareholders agreed to a distribution of CHF 0.42 per share with 99.90 %. This distribution, which is stable compared to previous years, shall be implemented by way of a reduction of the par value.

»Clariant has resolved legacy issues, sharpened the portfolio, and built a high-performance operating model – and this all in parallel,« said Ben van Beurden, Chairman of Clariant’s Board of Directors. »The chemical industry will continue to face challenges, but Clariant has the strategy, the portfolio, the innovation pipeline, the execution capability, and the people to outperform and create value for all stakeholders in the years ahead.«

Conrad Keijzer, Chief Executive Officer of Clariant, added: »2025 was the year in which Clariant proved its resilience and adaptability. We were able to improve our performance again through our own efforts – and that against strong headwinds. We did our homework. We streamlined our structures. We significantly reduced our costs. And we directed our innovation capacity to where it creates the greatest value.«

Further, Dr. Balthasar Settelen, attorney, was reelected as independent proxy until the next Annual General Meeting, and KPMG was confirmed as the statutory auditor for 2026.

The proposal for total compensation of the Board of Directors for the term from the 2026 to the 2027 Annual General Meeting was approved with 96.21 % of the votes, as was the total compensation of the Executive Steering Committee for the 2026 fiscal year, with 93.63 % of the votes.

Please find additional documents related to the AGM available for download on https://www.clariant.com/agm

Attachment

• Clariant Media Release 31st Annual General Meeting EN 20260401